Cell-Penetrable Peptide-Conjugated FADD Induces Apoptosis and Regulates Inflammatory Signaling in Cancer Cells
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Dysregulated expression of Fas-associated death domain (FADD) is associated with the impediment of various cellular pathways, including apoptosis and inflammation. The adequate cytosolic expression of FADD is critical to the regulation of cancer cell proliferation. Importantly, cancer cells devise mechanisms to suppress FADD expression and, in turn, escape from apoptosis signaling. Formulating strategies, for direct delivery of FADD proteins into cancer cells in a controlled manner, may represent a promising therapeutic approach in cancer therapy. We chemically conjugated purified FADD protein with cell permeable TAT (transactivator of transcription) peptide, to deliver in cancer cells. TAT-conjugated FADD protein internalized through the caveolar pathway of endocytosis and retained in the cytosol to augment cell death. Inside cancer cells, TAT-FADD rapidly constituted DISC (death inducing signaling complex) assembly, which in turn, instigate apoptosis signaling. The apoptotic competency of TAT-FADD showed comparable outcomes with the conventional apoptosis inducers. Notably, TAT-FADD mitigates constitutive NF-κB activation and associated downstream anti-apoptotic genes Bcl2, cFLIPL, RIP1, and cIAP2, independent of pro-cancerous TNF-α priming. In cancer cells, TAT-FADD suppresses the canonical NLRP3 inflammasome priming and restricts the processing and secretion of proinflammatory IL-1β. Our results demonstrate that TAT-mediated intracellular delivery of FADD protein can potentially recite apoptosis signaling with simultaneous regulation of anti-apoptotic and proinflammatory NF-κB signaling activation in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Caveolin pathways successfully encapsulate large molecules and prevent lysosomal degradation to retain the functional activity of molecules [100].”
From Insights of Endocytosis Signaling in Health and Disease (2023) · cites this paper as [100]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 2×
“The NF‐κB‐activated transcriptional priming of pro‐IL1β was further processed through the NLRP3 inflammasome complex to secret mature IL1β [28,29].”
BackgroundSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · cited 2×
“The NF‐κB‐activated transcriptional priming of pro‐IL1β was further processed through the NLRP3 inflammasome complex to secret mature IL1β [28,29].”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Mechanism and Regulation of NLRP3 Inflammasome Activation
He, Y., Hara, H., & Núñez, G. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.09.002 · Cited by 2,759
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738 · cited 1×
“The canonical activation of NF-κB is triggered upon ligation of TNF-α to its cognate receptor TNF receptor 1 (TNF-R1), leading to subsequent recruitment of TNF-R1-associated death domain (TRADD), FADD, TNF receptor-associated factor 2 (TRAF2), receptor-interacting protein kinase (RIP1), and the cellular inhibitor of a…”
BackgroundNF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Tat-mediated delivery of heterologous proteins into cells.
Fawell, S., Seery, J., Daikh, Y., Moore, C., Chen, L. L., Pepinsky, B., & Barsoum, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.664 · Cited by 1,225 · cited 1×
“The purified FADD protein was conjugated with TAT peptide as per [69] with minor modifications.”
MethodNF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
Ea, C.-K., Deng, L., Xia, Z.-P., Pineda, G., & Chen, Z. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.026 · Cited by 1,000
In vitro and ex vivo strategies for intracellular delivery
Stewart, M. P., Sharei, A., Ding, X., Sahay, G., Langer, R., & Jensen, K. F. (2016) · Nature · doi:10.1038/nature19764 · Cited by 885
Julien, O., & Wells, J. A. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.44 · Cited by 816 · cited 2×
“Indeed, the constituted DISC assembly concomitantly activates the canonical apoptosis signaling [5,6].”
BackgroundFas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
Siegel, R. M., Frederiksen, J. K., Zacharias, D. A., Chan, F. K.-M., Johnson, M., Lynch, D., Tsien, R. Y., & Lenardo, M. J. (2000) · Science · doi:10.1126/science.288.5475.2354 · Cited by 662 · cited 1×
“Upon internalization, TAT-FADD interacts with pro-apoptotic caspase-8 and anti-apoptotic cFLIPL protein to formulate DISC assembly in cancer cells, independent of death receptor activation to instigate downstream signaling [61].”
BackgroundIκB kinases: key regulators of the NF-κB pathway
Yamamoto, Y., & Gaynor, R. B. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.003 · Cited by 640
Gurung, P., Anand, P. K., Malireddi, R. K. S., Vande Walle, L., Van Opdenbosch, N., Dillon, C. P., Weinlich, R., Green, D. R., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302839 · Cited by 558
Staudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485 · cited 1×
“Several studies investigated constitutive NF-κB activation in cancer cells [22,24,43].”
BackgroundCell Membrane Lipid Rafts Mediate Caveolar Endocytosis of HIV-1 Tat Fusion Proteins
Fittipaldi, A., Ferrari, A., Zoppé, M., Arcangeli, C., Pellegrini, V., Beltram, F., & Giacca, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303045200 · Cited by 475 · cited 3×
“In order to protect the endosomal degradation of conjugated cargoes, TAT peptide prefers caveolin-mediated endocytosis [41,42].”
BackgroundCharacterisation of cell‐penetrating peptide‐mediated peptide delivery
Jones, S. W., Christison, R., Bundell, K., Voyce, C. J., Brockbank, S. M. V., Newham, P., & Lindsay, M. A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706279 · Cited by 385 · cited 1×
“The recent developments in therapeutic applications of small cell-penetrating peptides (CPPs), such as TAT (trans-acting activator of transcription) peptides, have been successfully validated to transport macromolecules, such as nucleic acids and proteins, across the cell membrane [39,40].”
BackgroundThe Fas–FADD death domain complex structure unravels signalling by receptor clustering
Scott, F. L., Stec, B., Pop, C., Dobaczewska, M. K., Lee, J. J., Monosov, E., Robinson, H., Salvesen, G. S., Schwarzenbacher, R., & Riedl, S. J. (2009) · Nature · doi:10.1038/nature07606 · Cited by 384 · cited 16×
“Post DR stimulation, the immediate process is FADD-mediated constitution of DISC assembly for the downstream activation of apoptosis signaling [3,4], as we observed TAT-FADD readily formulated DISC assembly, independent of DR stimulation, and this was sufficient to induce apoptosis signaling in cancer cells.”
BackgroundInfluentialCaveolae-Mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
Ferrari, A., Pellegrini, V., Arcangeli, C., Fittipaldi, A., Giacca, M., & Beltram, F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00122-9 · Cited by 335 · cited 3×
“In order to protect the endosomal degradation of conjugated cargoes, TAT peptide prefers caveolin-mediated endocytosis [41,42].”
BackgroundBossaller, L., Chiang, P.-I., Schmidt-Lauber, C., Ganesan, S., Kaiser, W. J., Rathinam, V. A. K., Mocarski, E. S., Subramanian, D., Green, D. R., Silverman, N., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202121 · Cited by 290
Activation of NF-κB by FADD, Casper, and Caspase-8
Hu, W.-H., Johnson, H., & Shu, H.-B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.10838 · Cited by 288
Regulatable gene expression systems for gene therapy applications: progress and future challenges
Goverdhana, S., Puntel, M., Xiong, W., Zirger, J. M., Barcia, C., Curtin, J. F., Soffer, E. B., Mondkar, S., King, G. D., Hu, J., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.022 · Cited by 283 · cited 1×
“However, vector-based gene delivery systems are under the control of host-derived factors and possess limited control over expression [58].”
Backgroundc-FLIPR, a New Regulator of Death Receptor-induced Apoptosis
Golks, A., Brenner, D., Fritsch, C., Krammer, P. H., & Lavrik, I. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414425200 · Cited by 282 · cited 1×
“The canonical activation of NF-κB is triggered upon ligation of TNF-α to its cognate receptor TNF receptor 1 (TNF-R1), leading to subsequent recruitment of TNF-R1-associated death domain (TRADD), FADD, TNF receptor-associated factor 2 (TRAF2), receptor-interacting protein kinase (RIP1), and the cellular inhibitor of a…”
BackgroundActivation of the NF-κB pathway by Caspase 8 and its homologs
Chaudhary, P. M., Eby, M. T., Jasmin, A., Kumar, A., Liu, L., & Hood, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203812 · Cited by 242
Hierarchies of NF-κB target-gene regulation
Smale, S. T. (2011) · Nature Immunology · doi:10.1038/ni.2070 · Cited by 238
Kataoka, T., & Tschopp, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2627-2636.2004 · Cited by 235
FADD: a regulator of life and death
Tourneur, L., & Chiocchia, G. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.05.005 · Cited by 203 · cited 1×
“The adaptor protein FADD provides scaffolding for the recruitment of various signaling proteins involves in distinct cellular pathways, including apoptosis and inflammation [1,52].”
BackgroundThe c-FLIP–NH2 terminus (p22-FLIP) induces NF-κB activation
Golks, A., Brenner, D., Krammer, P. H., & Lavrik, I. N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051556 · Cited by 187
Phosphorylation of FADD at Serine 194 by CKIα Regulates Its Nonapoptotic Activities
Alappat, E. C., Feig, C., Boyerinas, B., Volkland, J., Samuels, M. A., Murmann, A. E., Thorburn, A. M., Kidd, V. J., Slaughter, C. A., Osborn, S. L., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.024 · Cited by 166 · cited 1×
“This impediment is likely because of post-translational modifications (PTMs) and nuclear localization of FADD [9,10,56].”
BackgroundMammalian initiator apoptotic caspases
Ho, P., & Hawkins, C. J. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.04966.x · Cited by 162 · cited 1×
“Indeed, the constituted DISC assembly concomitantly activates the canonical apoptosis signaling [5,6].”
BackgroundRecent Advances in Anti-cancer Protein/Peptide Delivery
Liu, X., Wu, F., Ji, Y., & Yin, L. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00750 · Cited by 161
Chen, G., Bhojani, M. S., Heaford, A. C., Chang, D. C., Laxman, B., Thomas, D. G., Griffin, L. B., Yu, J. B., Coppola, J. M., Giordano, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500397102 · Cited by 150
Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies
Nagel, D., Vincendeau, M., Eitelhuber, A. C., & Krappmann, D. (2014) · Oncogene · doi:10.1038/onc.2013.565 · Cited by 142 · cited 2×
“Noteworthy, a constitutive NF-κB activation, leads to aberrant transcriptional priming of anti-apoptotic genes, such as Bcl-2, TRAF2, cFLIP, cIAPs, and RIP1 which further abrogates apoptosis signaling [22,24].”
BackgroundLee, E., Kim, J.-H., Ahn, Y.-H., Seo, J., Ko, A., Jeong, M., Kim, S.-J., Ro, J. Y., Park, K.-M., Lee, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms1981 · Cited by 138
Okano, H., Shiraki, K., Inoue, H., Kawakita, T., Yamanaka, T., Deguchi, M., Sugimoto, K., Sakai, T., Ohmori, S., Fujikawa, K., et al. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000079328.76631.28 · Cited by 132 · cited 1×
“In cancer cells, the DED-containing protein cFLIPL (cellular FLICE inhibitory protein) competitively exclude caspase-8 binding to FADD at DISC and inhibits apoptosis signaling [7,8].”
BackgroundMolecular evidence for the nuclear localization of FADD
Gómez-Angelats, M., & Cidlowski, J. A. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401237 · Cited by 122 · cited 1×
“This impediment is likely because of post-translational modifications (PTMs) and nuclear localization of FADD [9,10,56].”
BackgroundProtein Delivery into the Cell Cytosol using Non-Viral Nanocarriers
Lee, Y.-W., Luther, D. C., Kretzmann, J. A., Burden, A., Jeon, T., Zhai, S., & Rotello, V. M. (2019) · Theranostics · doi:10.7150/thno.34412 · Cited by 118
SAU, A. C., Lau, R., Cabrita, M. A., Nolan, E., Crooks, P. A., Visvader, J. E., & Pratt, M. A. C. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.05.003 · Cited by 117 · cited 1×
“On the other side, pathogen recognition receptor (PRR)-mediated NF-κB activation induces transcriptional priming of proinflammatory genes to maintain the tumor microenvironment [25,26].”
BackgroundFADD at the Crossroads between Cancer and Inflammation
Mouasni, S., & Tourneur, L. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.10.005 · Cited by 96 · cited 2×
“The Fas-associated death domain (FADD) protein orchestrates several cellular pathways, including apoptosis, cell cycle regulation, autophagy, and inflammation [1,2].”
BackgroundThe active caspase-8 heterotetramer is formed at the CD95 DISC
Lavrik, I. N., Krueger, A., Schmitz, I., Baumann, S., Weyd, H., Krammer, P. H., & Kirchhoff, S. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401156 · Cited by 92
NF-κB in the New Era of Cancer Therapy
Eluard, B., Thiéblemont, C., & Baud, V. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.04.003 · Cited by 91
Tourneur, L., Delluc, S., Lévy, V., Valensi, F., Radford-Weiss, I., Legrand, O., Vargaftig, J., Boix, C., Macintyre, E. A., Varet, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2361 · Cited by 76
Tourneur, L., Mistou, S., Michiels, F.-M., Devauchelle‐Pensec, V., Rénia, L., Feunteun, J., & Chiocchia, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206399 · Cited by 67 · cited 1×
“The expression of FADD in cancer cells is relatively low [13,15,54,55], and some studies have contributed that at low levels, FADD may contribute to NF-κB activation [64,65], while, seemingly in contrast to these studies, we and others reported that induced expression of FADD regulates NF-κB activation [18,30].”
ResultPeptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors
Jafari, B., Pourseif, M. M., Barar, J., Rafi, M. A., & Omidi, Y. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1614911 · Cited by 65 · cited 1×
“The recent developments in therapeutic applications of small cell-penetrating peptides (CPPs), such as TAT (trans-acting activator of transcription) peptides, have been successfully validated to transport macromolecules, such as nucleic acids and proteins, across the cell membrane [39,40].”
BackgroundKobayashi, T., Okamoto, K., Kobata, T., Hasunuma, T., Kato, T., Hamada, H., & Nishioka, K. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301127 · Cited by 64 · cited 2×
“In this context, few studies investigated the vector-based FADD gene therapy approach in regulation of tumor growth [32–34] and apoptosis in synoviocytes [35]; however, adenoviral or vector-based approaches have limited control over protein expression and host-derived factors.”
BackgroundThe Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β
Bannerman, D. D., Tupper, J. C., Kelly, J. D., Winn, R. K., & Harlan, J. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214774 · Cited by 62
Recent developments in intracellular protein delivery
Zhang, Y., Røise, J. J., Lee, K., Li, J., & Murthy, N. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.02.009 · Cited by 60
Mouasni, S., Gonzalez, V., Schmitt, A., Bennana, E., Guillonneau, F., Mistou, S., Avouac, J., Ea, H., Devauchelle‐Pensec, V., Gottenberg, J., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1412-9 · Cited by 60 · cited 1×
“A recent report revealed that canonical NLRP3 inflammasome activation induces the secretion of soluble FADD protein in human monocytes and macrophages [31]; however, the exact molecular mechanism of FADD, in the regulation of NLRP3 inflammasome signaling is less explored in the context of apoptosis.”
BackgroundFADD in Cancer: Mechanisms of Altered Expression and Function, and Clinical Implications
Marín‐Rubio, J. L., Vela‐Martín, L., Fernández‐Piqueras, J., & Villa‐Morales, M. (2019) · Cancers · doi:10.3390/cancers11101462 · Cited by 60 · cited 1×
“The expression of FADD in cancer cells is relatively low [13,15,54,55], and some studies have contributed that at low levels, FADD may contribute to NF-κB activation [64,65], while, seemingly in contrast to these studies, we and others reported that induced expression of FADD regulates NF-κB activation [18,30].”
ResultKorkolopoulou, P. A., Saetta, A. A., Levidou, G., Gigelou, F., Lazaris, A. C., Thymara, I., Scliri, M., Bousboukea, K., Michalopoulos, N. V., Apostolikas, N., et al. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02723.x · Cited by 54 · cited 1×
“Moreover, somatic mutation in FADD [16] and elevated expression of cFLIP [17] has been attributed in the pathogenesis of colon carcinoma.”
BackgroundFADD Gene Therapy for Malignant Gliomas In Vitro and In Vivo
Kondo, S., Ishizaka, Y., Okada, T., Kondo, Y., Hitomi, M., Tanaka, Y., Haqqi, T., Barnett, G. H., & Barna, B. P. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.11-1599 · Cited by 53
FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis
Ranjan, K., & Pathak, C. (2016) · Scientific Reports · doi:10.1038/srep22787 · Cited by 53 · cited 6×
“This is similar to our previous report showing that FADD induces the degradation of cFLIPL and recruits caspase-8 at DISC to instigate apoptosis signaling [18].”
BackgroundResultSelf-citationBalance between short and long isoforms of cFLIP regulates Fas-mediated apoptosis in vivo
Ram, D. R., Ilyukha, V., Volkova, T. O., Buzdin, A. A., Tai, A., Smirnova, I., & Poltorak, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517562113 · Cited by 51 · cited 1×
“In cancer cells, the DED-containing protein cFLIPL (cellular FLICE inhibitory protein) competitively exclude caspase-8 binding to FADD at DISC and inhibits apoptosis signaling [7,8].”
BackgroundEmerging Roles for the Death Adaptor FADD in Death Receptor Avidity and Cell Cycle Regulation
Werner, M. H., Wu, C., & Walsh, C. M. (2006) · Cell Cycle · doi:10.4161/cc.5.20.3385 · Cited by 39
FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer
Cimino, Y., Costes, A., Damotte, D., Validire, P., Mistou, S., Cagnard, N., Alifano, M., Régnard, J. F., Chiocchia, G., Sautès‐Fridman, C., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.196 · Cited by 35
Komata, T., Koga, S., Hirohata, S., Takakura, M., Germano, I., Inoue, M., Kyo, S., Kondo, S., & Kondo, Y. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.5.1015 · Cited by 35
Baratchian, M., Davis, C. A., Shimizu, A., Escors, D., Bagnéris, C., Barrett, T. E., & Collins, M. K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718122 · Cited by 28
Ranjan, K., Sharma, A., Surolia, A., & Pathak, C. (2014) · BioFactors · doi:10.1002/biof.1098 · Cited by 27 · cited 2×
“Cells were subjected to treatments as mentioned in the figure legends and the change in mitochondrial membrane potential (∆Ψm) was determined by using JC-1 fluorescent dye (BioVision) as previously described [70].”
MethodSelf-citationCell-Penetrating TAT-FOXO3 Fusion Proteins Induce Apoptotic Cell Death in Leukemic Cells
Essafi, M., Baudot, A. D., Mouska, X., Cassuto, J., Ticchioni, M., & Deckert, M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0482 · Cited by 26 · cited 1×
“Similarly, previous studies demonstrated TAT encoding vectors for the exogenous delivery of proteins [59,60].”
ResultSynergy of BID with doxorubicin in the killing of cancer cells
Orzechowska-Licari, E. J., Girstun, A., Staroń, K., & Trzcińska‐Danielewicz, J. (2015) · Oncology Reports · doi:10.3892/or.2015.3841 · Cited by 25 · cited 1×
“It is possible that each apoptosis-inducing protein has a different expression regulation and concentration-dependent effect in cancer cells [60,62].”
BackgroundControlled delivery of BID protein fused with TAT peptide sensitizes cancer cells to apoptosis
Orzechowska-Licari, E. J., Kozłowska, E., Czubaty, A., Kozlowski, P., Staroń, K., & Trzcińska‐Danielewicz, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-771 · Cited by 24 · cited 3×
“It is possible that each apoptosis-inducing protein has a different expression regulation and concentration-dependent effect in cancer cells [60,62].”
BackgroundResultRanjan, K., Surolia, A., & Pathak, C. (2012) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-012-0166-2 · Cited by 23 · cited 2×
“The cDNA was then amplified and analyzed by RT-qPCR as previously described [19].”
MethodSelf-citationYang, Y., Zhang, C., Huang, X.-J., Zhang, X.-X., Zhang, L.-K., Li, J., & Hua, Z. (2016) · Scientific Reports · doi:10.1038/srep34178 · Cited by 21 · cited 3×
“We and others have previously shown that FADD has the potential to reactivate apoptosis, if sufficiently expressed in cancer cells [18,34].”
BackgroundResultS194-P-FADD as a marker of aggressiveness and poor prognosis in human T-cell lymphoblastic lymphoma
Marín‐Rubio, J. L., Pérez-Gómez, E., Fernández‐Piqueras, J., & Villa‐Morales, M. (2019) · Carcinogenesis · doi:10.1093/carcin/bgz041 · Cited by 17 · cited 1×
“The expression of FADD in cancer cells is relatively low [13,15,54,55], and some studies have contributed that at low levels, FADD may contribute to NF-κB activation [64,65], while, seemingly in contrast to these studies, we and others reported that induced expression of FADD regulates NF-κB activation [18,30].”
ResultRanjan, K., & Pathak, C. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2813-z · Cited by 16
Self-citationSubcellular compartmentalization of FADD as a new level of regulation in death receptor signaling
Föger, N., Bulfone‐Paus, S., Chan, A. C., & Lee, K. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07134.x · Cited by 15 · cited 1×
“This impediment is likely because of post-translational modifications (PTMs) and nuclear localization of FADD [9,10,56].”
BackgroundDeregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma
Marín‐Rubio, J. L., de Arriba, M. D. C., Cobos-Fernández, M., González-Sánchez, L., Ors, I., Sastre, I., Fernández‐Piqueras, J., & Villa‐Morales, M. (2016) · Oncotarget · doi:10.18632/oncotarget.11370 · Cited by 14 · cited 1×
“The expression of FADD in cancer cells is relatively low [13,15,54,55], and some studies have contributed that at low levels, FADD may contribute to NF-κB activation [64,65], while, seemingly in contrast to these studies, we and others reported that induced expression of FADD regulates NF-κB activation [18,30].”
ResultMutation of FADD gene is rare in human colon and stomach cancers
Soung, Y. H., Lee, J. W., Kim, S. Y., Nam, S. W., Park, W. S., Kim, S. H., LEE, J. Y., Yoo, N. J., & Lee, S. H. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120906.x · Cited by 9
Cited by
Lv, C., Kang, W., Liu, S., Yang, P., Nishina, Y., Ge, S., Bianco, A., & Ma, B. (2022) · ACS Nano · doi:10.1021/acsnano.2c05532 · Cited by 133
Insights of Endocytosis Signaling in Health and Disease
Pathak, C., Vaidya, F. U., Waghela, B. N., Jaiswara, P. K., Gupta, V. K., Kumar, A., Rajendran, B. K., & Ranjan, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032971 · Cited by 59
“Caveolin pathways successfully encapsulate large molecules and prevent lysosomal degradation to retain the functional activity of molecules [100].”
BackgroundSelf-citationFADD as a key molecular player in cancer progression
Liu, Y., Li, X., Zhou, X., Wang, J., & Ao, X. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00560-y · Cited by 51
“Luciferase reporter and quantitative real-time polymerase chain reaction (qRT-PCR) assays showed that TAT-FADD significantly reduced the activation of NF-κB in HCT-116 cells, leading to the inhibition of anti-apoptotic genes, including Bcl2, cIAPs, RIP1, and cFLIPL (Ranjan et al. 2020).”
MethodUnleashing cell-penetrating peptide applications for immunotherapy
Koo, J., Kim, G., Nam, K.-H., & Choi, J. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.03.010 · Cited by 45
Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and Inflammation
Ranjan, K., & Pathak, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063228 · Cited by 37
Self-citation
Metadata
- Authors
- Ranjan, K., Waghela, B. N., Vaidya, F. U., & Pathak, C.
- Affiliations
- Indian Institute of Advanced Research (IN)
- Corresponding author
- Pathak, Chandramani
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-09-19
- Volume
- 21
- Issue
- 18
- Pages
- 6890
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7555701
- OpenAlex
- W3087422657
- Cited by
- 24
- References
- 70
- Citations by year
- 2025: 4 · 2024: 6 · 2023: 3 · 2022: 8 · 2021: 3
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Department of Biotechnology, Ministry of Science and Technology, India (6242/P60/RGCB/PMD/DBT/CMPK/2015)
- Department of Science & Technology (EMR/2016/002574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- FADD, cell-penetrating peptides, apoptosis, NF-κB signaling, NLRP3 inflammasome, IL-1β, death-inducing signaling complex, caveolar endocytosis, anti-apoptotic proteins, cancer therapy, protein delivery
- MeSH terms
- RAW 264.7 Cells, Animals, Gene Expression Regulation, HeLa Cells, Humans, Neoplasm Proteins, Neoplasms, Apoptosis, HCT116 Cells, Mice, Fas-Associated Death Domain Protein, Hep G2 Cells, HEK293 Cells, Cell-Penetrating Peptides, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.